| Bryan Morrow, PT | |
|
100 Walter Ward Blvd Ste 200, Abingdon, MD 21009-1285 | |
| (443) 512-8337 | |
| Not Available |
| Full Name | Bryan Morrow |
|---|---|
| Gender | Male |
| Speciality | Physical Therapy |
| Experience | 22 Years |
| Location | 100 Walter Ward Blvd Ste 200, Abingdon, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093760670 | NPI | - | NPPES |
| P00359635 | Other | MEDICARE RAILROAD | |
| 1093760670 | Medicaid | DE | |
| 2520044 | Medicaid | MD | |
| 000051070 | Other | DE | DPCI |
| 2181808000 | Other | DE | AMERIHEALTH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | J2001723 (Delaware) | Secondary |
| 225100000X | Physical Therapist | 23639 (Maryland) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Innovative Physical Therapy And Fitness Centers Llc | 3870864648 | 12 |
| Innovative Physical Therapy And Fitness Centers Llc | 3870864648 | 12 |
News Archive
EntreMed, Inc., today announced the addition of Dana Farber/Harvard Cancer Center (DF/HCC) to the Phase 2 multi-center study entitled "A Phase 2 Study of Oral ENMD-2076 Administered to Patients with Platinum Resistant Ovarian Cancer." Ursula Matulonis, M.D., Associate Professor of Medicine, Dana-Farber Cancer Institute and Harvard Medical School, will serve as principal investigator.
The U.S. Department of Commerce's National Institute of Standards and Technology (NIST) has awarded a total of $50 million in emergency funding to support U.S. manufacturers in their response to the COVID-19 pandemic.
As the COVID-19 pandemic progresses with little prospect of immediate relief, a recent study by Johns Hopkins University researchers published on the preprint server medRxiv* in October 2020 discusses the association of Immunoglobulin M (IgM) autoantibodies against the host receptor that binds severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with severe disease via vascular endothelial damage. This could help develop better therapies and prognostic criteria.
The inherited breast/ovarian cancer genes are BRCA1 and BRCA2, which are associated with an increased risk of breast and/or ovarian cancer. The results are part of a five–year study of a common form of early stage breast cancer called ductal carcinoma in situ (DCIS).
GeckoSystems Intl. Corp. announced today that during their first annual "Mobile Robots in Motion" conference last week, a first tier contract manufacturer after viewing numerous demonstrations, examining and discussing GeckoSystems' first product, the CareBot™ is confident that within six months they could produce GeckoSystems' CareBot at the rate of one thousand (1,000) per month.
› Verified 3 days ago
| Provider Name | Innovative Physical Therapy And Fitness Centers Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1710411558 PECOS PAC ID: 3870864648 Enrollment ID: O20170814000184 |
News Archive
EntreMed, Inc., today announced the addition of Dana Farber/Harvard Cancer Center (DF/HCC) to the Phase 2 multi-center study entitled "A Phase 2 Study of Oral ENMD-2076 Administered to Patients with Platinum Resistant Ovarian Cancer." Ursula Matulonis, M.D., Associate Professor of Medicine, Dana-Farber Cancer Institute and Harvard Medical School, will serve as principal investigator.
The U.S. Department of Commerce's National Institute of Standards and Technology (NIST) has awarded a total of $50 million in emergency funding to support U.S. manufacturers in their response to the COVID-19 pandemic.
As the COVID-19 pandemic progresses with little prospect of immediate relief, a recent study by Johns Hopkins University researchers published on the preprint server medRxiv* in October 2020 discusses the association of Immunoglobulin M (IgM) autoantibodies against the host receptor that binds severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with severe disease via vascular endothelial damage. This could help develop better therapies and prognostic criteria.
The inherited breast/ovarian cancer genes are BRCA1 and BRCA2, which are associated with an increased risk of breast and/or ovarian cancer. The results are part of a five–year study of a common form of early stage breast cancer called ductal carcinoma in situ (DCIS).
GeckoSystems Intl. Corp. announced today that during their first annual "Mobile Robots in Motion" conference last week, a first tier contract manufacturer after viewing numerous demonstrations, examining and discussing GeckoSystems' first product, the CareBot™ is confident that within six months they could produce GeckoSystems' CareBot at the rate of one thousand (1,000) per month.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Bryan Morrow, PT 100 Walter Ward Blvd Ste 200, Abingdon, MD 21009-1285 Ph: (443) 512-8337 | Bryan Morrow, PT 100 Walter Ward Blvd Ste 200, Abingdon, MD 21009-1285 Ph: (443) 512-8337 |
News Archive
EntreMed, Inc., today announced the addition of Dana Farber/Harvard Cancer Center (DF/HCC) to the Phase 2 multi-center study entitled "A Phase 2 Study of Oral ENMD-2076 Administered to Patients with Platinum Resistant Ovarian Cancer." Ursula Matulonis, M.D., Associate Professor of Medicine, Dana-Farber Cancer Institute and Harvard Medical School, will serve as principal investigator.
The U.S. Department of Commerce's National Institute of Standards and Technology (NIST) has awarded a total of $50 million in emergency funding to support U.S. manufacturers in their response to the COVID-19 pandemic.
As the COVID-19 pandemic progresses with little prospect of immediate relief, a recent study by Johns Hopkins University researchers published on the preprint server medRxiv* in October 2020 discusses the association of Immunoglobulin M (IgM) autoantibodies against the host receptor that binds severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with severe disease via vascular endothelial damage. This could help develop better therapies and prognostic criteria.
The inherited breast/ovarian cancer genes are BRCA1 and BRCA2, which are associated with an increased risk of breast and/or ovarian cancer. The results are part of a five–year study of a common form of early stage breast cancer called ductal carcinoma in situ (DCIS).
GeckoSystems Intl. Corp. announced today that during their first annual "Mobile Robots in Motion" conference last week, a first tier contract manufacturer after viewing numerous demonstrations, examining and discussing GeckoSystems' first product, the CareBot™ is confident that within six months they could produce GeckoSystems' CareBot at the rate of one thousand (1,000) per month.
› Verified 3 days ago
Align Rehabilitation Llc Physical Therapist Medicare: Medicare Enrolled Practice Location: 3435 Box Hill Corporate Center Dr Ste D, Abingdon, MD 21009 Phone: 908-458-3527 | |
Dana Cross, M.S.P.T. Physical Therapist Medicare: Medicare Enrolled Practice Location: 101 Walter Ward Blvd, Abingdon, MD 21009 Phone: 443-409-0051 Fax: 443-409-0058 | |
Kiersten Elizabeth Kilczewski, PT, DPT, CLT-LANA Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 101 Walter Ward Blvd, Abingdon, MD 21009 Phone: 443-409-0051 Fax: 443-409-0058 | |
Victoria Grace Shogren, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 100 Walter Ward Blvd Ste 200, Abingdon, MD 21009 Phone: 443-512-8337 Fax: 443-327-5282 | |
Mrs. Melissa Tutas, MSPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3465 Box Hill Corporate Center Dr, Suite G, Abingdon, MD 21009 Phone: 410-569-4806 Fax: 410-569-5474 | |
Jacquelin Landsman, MPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: Upper Chesapeake Orthopedics: Center For Sports Med, 101 Walter Ward Blvd, Abingdon, MD 21009 Phone: 443-643-1801 |